115 related articles for article (PubMed ID: 9335010)
1. Altered tumor growth factor beta mRNA expression is associated with thymectomy-related clinical remission in myasthenia gravis.
Weissert R; Melms A; Link H
J Neurol Sci; 1997 Oct; 151(1):49-55. PubMed ID: 9335010
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
Link J
Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
[TBL] [Abstract][Full Text] [Related]
3. Augmented interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in blood mononuclear cells in myasthenia gravis.
Link J; Navikas V; Yu M; Fredrikson S; Osterman PO; Link H
J Neuroimmunol; 1994 May; 51(2):185-92. PubMed ID: 8182116
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta 1 suppresses autoantigen-induced expression of pro-inflammatory cytokines but not of interleukin-10 in multiple sclerosis and myasthenia gravis.
Link J; He B; Navikas V; Palasik W; Fredrikson S; Söderström M; Link H
J Neuroimmunol; 1995 Apr; 58(1):21-35. PubMed ID: 7537278
[TBL] [Abstract][Full Text] [Related]
5. Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells.
Ma CG; Zhang GX; Xiao BG; Wang ZY; Link J; Olsson T; Link H
Ann N Y Acad Sci; 1996 Feb; 778():273-87. PubMed ID: 8610980
[TBL] [Abstract][Full Text] [Related]
6. Organ-specific autoantigens induce transforming growth factor-beta mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis.
Link J; Fredrikson S; Söderström M; Olsson T; Höjeberg B; Ljungdahl A; Link H
Ann Neurol; 1994 Feb; 35(2):197-203. PubMed ID: 7509140
[TBL] [Abstract][Full Text] [Related]
7. Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis.
Wang ZY; Link H; Ljungdahl A; Höjeberg B; Link J; He B; Qiao J; Melms A; Olsson T
Cell Immunol; 1994 Sep; 157(2):353-68. PubMed ID: 7520837
[TBL] [Abstract][Full Text] [Related]
8. Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG).
Ma CG; Zhang GX; Xiao BG; Link H
Clin Exp Immunol; 1996 Jun; 104(3):509-16. PubMed ID: 9099937
[TBL] [Abstract][Full Text] [Related]
9. The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis.
Navikas V; Matusevicius D; Söderström M; Pirskanen R; Fredrikson S; Link H
Clin Neuropharmacol; 1998; 21(4):236-44. PubMed ID: 9704165
[TBL] [Abstract][Full Text] [Related]
10. Cytokines and the pathogenesis of myasthenia gravis.
Zhang GX; Navikas V; Link H
Muscle Nerve; 1997 May; 20(5):543-51. PubMed ID: 9140360
[TBL] [Abstract][Full Text] [Related]
11. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis.
Ponseti JM; Gamez J; Vilallonga R; Ruiz C; Azem J; López-Cano M; Armengol M
Eur J Cardiothorac Surg; 2008 Nov; 34(5):1062-7. PubMed ID: 18760934
[TBL] [Abstract][Full Text] [Related]
12. Delayed remission after thymectomy for myasthenia gravis of the purely ocular type.
Nakamura H; Taniguchi Y; Suzuki Y; Tanaka Y; Ishiguro K; Fukuda M; Hara H; Mori T
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):371-5. PubMed ID: 8751505
[TBL] [Abstract][Full Text] [Related]
13. Nasal administration of multiple antigens suppresses experimental autoimmune myasthenia gravis, encephalomyelitis and neuritis.
Shi FD; Bai XF; Xiao BG; van der Meide PH; Link H
J Neurol Sci; 1998 Feb; 155(1):1-12. PubMed ID: 9562316
[TBL] [Abstract][Full Text] [Related]
14. Transsternal thymectomy for myasthenia gravis: surgical outcome.
Kattach H; Anastasiadis K; Cleuziou J; Buckley C; Shine B; Pillai R; Ratnatunga C
Ann Thorac Surg; 2006 Jan; 81(1):305-8. PubMed ID: 16368387
[TBL] [Abstract][Full Text] [Related]
15. Increased transforming growth factor-beta, interleukin-4, and interferon-gamma in multiple sclerosis.
Link J; Söderström M; Olsson T; Höjeberg B; Ljungdahl A; Link H
Ann Neurol; 1994 Sep; 36(3):379-86. PubMed ID: 8080246
[TBL] [Abstract][Full Text] [Related]
16. Eight-year follow-up of patients with myasthenia gravis after thymectomy.
Yu S; Li F; Chen B; Lin J; Yang M; Fu X; Li J; Bu B
Acta Neurol Scand; 2015 Feb; 131(2):94-101. PubMed ID: 25170783
[TBL] [Abstract][Full Text] [Related]
17. Two-year outcome of thymectomy with or without immunosuppressive treatment in nonthymomatous myasthenia gravis and its effect on regulatory T cells.
Jakubíková M; Piťha J; Marečková H; Týblová M; Nováková I; Schutzner J
J Neurol Sci; 2015 Nov; 358(1-2):101-6. PubMed ID: 26320610
[TBL] [Abstract][Full Text] [Related]
18. Decreased mRNA expression of TNF-alpha and IL-10 in non-stimulated peripheral blood mononuclear cells in myasthenia gravis.
Huang WX; Huang P; Fredrikson S; Pirskanen R; Hillert J
Eur J Neurol; 2000 Mar; 7(2):195-202. PubMed ID: 10809941
[TBL] [Abstract][Full Text] [Related]
19. Expression of IFN-gamma, IL-4, and TGF-beta in multiple sclerosis in relation to HLA-Dw2 phenotype and stage of disease.
Söderström M; Hillert J; Link J; Navikas V; Fredrikson S; Link H
Mult Scler; 1995 Nov; 1(3):173-80. PubMed ID: 9345450
[TBL] [Abstract][Full Text] [Related]
20. Active ectopic thymus predicts poor outcome after thymectomy in class III myasthenia gravis.
Ambrogi V; Mineo TC
J Thorac Cardiovasc Surg; 2012 Mar; 143(3):601-6. PubMed ID: 22177829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
